| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |